Posts

Showing posts with the label Ectodermal Dysplasia (ED)

Ectodermal Dysplasia (ED) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Ectodermal dysplasias (ED) encompasses over 180 disorders that impact the outer layer of embryonic tissue (ectoderm), which is responsible for forming the skin, sweat glands, hair, teeth, and nails. Additionally, organs like mammary glands, the central nervous system (CNS), external ears, melanocytes, cornea, conjunctiva, and lacrimal apparatus originate from the embryonic ectoderm. Mutations in EDA, EDAR, EDARADD, and WNT10A genes are implicated, with EDA mutations being the predominant cause, contributing to more than half of all cases. Symptoms of ectodermal dysplasias vary depending on the specific type and may differ even within affected families. Common mouth-related issues associated with ED include thinner or softer tooth enamel leading to increased cavities, missing or misshapen teeth, abnormal tooth and jaw positioning, reduced saliva production resulting in dry mouth, and occurrences of cleft lip or palate. Clinical evaluation of a patient exhibiting typical phenotypic ...

Ectodermal Dysplasia (ED) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Ectodermal dysplasias (ED) are a group of more than 180 disorders affecting the outer layer of embryo tissue (ectoderm) that helps make up the skin, sweat glands, hair, teeth, and nails. Mutations in EDA, EDAR, EDARADD, and WNT10A. EDA genes are the most common cause of the disorder, accounting for more than half of all cases. ·        The most common ectodermal dysplasia (ED) type is Hypohidrotic ectodermal dysplasia. It is estimated to occur in 1 in 20,000 newborns worldwide. Thelansis’s “Ectodermal Dysplasia (ED) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Ectodermal Dysplasia (ED) treatment modalities options for eight major markets (USA, Germany, France,...

Ectodermal Dysplasia (ED) – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
  Ectodermal dysplasias (ED) are a group of more than 180 disorders that affect the outer layer of tissue of the embryo (ectoderm) that helps make up the skin, sweat glands, hair, teeth, and nails.   Etiology- Mutations in  EDA, EDAR, EDARADD, and WNT10A. EDA genes are the most common cause of the disorder, accounting for more than half of all cases.   Epidemiology- Hypohidrotic ectodermal dysplasia is the most common form of ectodermal dysplasia. It is estimated to occur in 1 in 20,000 newborns worldwide.   The competitive landscape of Ectodermal Dysplasia (ED) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Ectodermal Dysplasia (ED) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscap...